Associations between CT characteristics of lung cancer lesions and histologic subtypes in lung cancer screening - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

CT Features of Lung Cancer Lesions and Their Associations With Histologic Subtypes in Screening Programs

  • By

  • Erick Suazo-Zepeda

  • Geertruida H. de Bock

  • Noa Antonissen

  • Colin Jacobs

  • Firdaus A. A. Mohamed Hoesein

  • Hester A. Gietema

  • Grigory Sidorenkov

  • Rozemarijn Vliegenthart

  • Marjolein A. Heuvelmans

  • October 7, 2026

Share

Clinical Report: CT Features of Lung Cancer Lesions and Histologic Subtypes

Overview

This retrospective observational cohort study within the NELSON-POP project examines associations between CT nodule characteristics and histologic subtype in lung cancers detected through screening. The supplied article excerpt describes the study rationale and methods but does not provide its results; therefore, subtype-specific findings from this analysis cannot be summarized.

Background

Lung cancer causes approximately 1.8 million deaths worldwide each year, and early detection is associated with improved survival. LDCT screening has shifted diagnoses toward earlier stages and reduced lung cancer mortality in randomized trials, although screening detection and mortality effects differ by histologic subtype. Adenocarcinoma is common among screen-detected cancers, while squamous cell carcinoma and small-cell lung cancer are more often diagnosed as interval cancers. The study was designed to assess whether radiologic features and growth parameters in screening-detected lesions are associated with histology.

Data Highlights

MeasureReported information
Worldwide lung cancer deathsApproximately 1.8 million annually
Stage I among screen-detected cancers53.1%–76.5% across randomized screening trials
Stage IIIB–IV among screen-detected cancersApproximately 8%
NLST mortality effect20% relative reduction with LDCT versus chest radiography
NELSON mortality effectReductions of 24% among men and up to 33% among women versus no screening, as reported in the supplied article
Histology in NELSON screen-detected cancersAdenocarcinoma: 52%; squamous cell carcinoma and small-cell lung cancer were more frequently interval cancers
Histology in NLST casesAdenocarcinoma: 54%; squamous cell carcinoma: 21%; small-cell lung cancer: 8%
LDCT mortality effect by histologyAdenocarcinoma: RR 0.75 (95% CI 0.60–0.94); squamous cell carcinoma: RR 1.08 (95% CI 0.86–1.31); small-cell lung cancer: RR 0.90 (95% CI 0.69–1.18)
Study population and follow-upNELSON participants recruited from 2003–2006; diagnostic and histologic confirmation follow-up continued through 2016

Key Findings

  • The study is a retrospective observational cohort analysis embedded in NELSON-POP and extends the NELSON randomized trial.
  • It evaluates radiologic nodule characteristics in histologically verified lung cancers detected through screening at Dutch study sites.
  • The study rationale notes that adenocarcinoma accounted for 52% of NELSON screen-detected cancers, while squamous cell carcinoma and small-cell lung cancer were more often interval cancers.
  • In NLST, adenocarcinoma represented 54% of cases, squamous cell carcinoma 21%, and small-cell lung cancer 8%.
  • The supplied background reports a statistically compatible mortality reduction for adenocarcinoma (RR 0.75; 95% CI 0.60–0.94), but not for squamous cell carcinoma or small-cell lung cancer.
  • The background describes non-solid adenocarcinoma nodules as often unchanged over brief follow-up, spiculated margins as more frequent in adenocarcinoma, and cavitation as a feature that may occur in squamous cell carcinoma; these distinctions are reported to be more evident in nodules larger than 1.5 cm.

Clinical Implications

The supplied article identifies histology-associated imaging patterns and nodule growth as questions relevant to risk stratification in screening, while noting diagnostic challenges for smaller nodules. Because the excerpt does not include the study's results, it does not support specific changes to nodule management or screening practice.

Conclusion

The NELSON-POP analysis was designed to characterize CT features associated with histologic subtypes in screening-detected lung cancers. Its findings are not included in the provided excerpt, so conclusions about the observed associations cannot be drawn here.

Related Resources & Content

  1. NELSON-POP study, article excerpt supplied, year not provided — CT Features of Lung Cancer Lesions and Their Associations With Histologic Subtypes in Screening Programs
  2. National Lung Screening Trial Research Team, New England Journal of Medicine, 2011 — Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
  3. U.S. Preventive Services Task Force, 2021 — Lung Cancer: Screening
  4. ASCO Publications — Lung cancer risk in persons enrolled in low-dose CT screening (LDCT) versus incidental lung nodule programs (ILNP).
  5. ASCO Publications — Deciphering molecular characters of multiple lung lesion using comprehensive genomic profiling and its association of histology.
  6. ASCO Publications — Lung cancer risk in persons enrolled in low-dose CT screening (LDCT) versus incidental lung nodule programs (ILNP).
  7. ASCO Publications — Impact of lung cancer screening in patients diagnosed with small cell lung cancer.
  8. Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce
  9. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening | New England Journal of Medicine
  10. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening | New England Journal of Medicine
  11. Imaging and Management of Subsolid Lung Nodules - PubMed

Original Source(s)

Related Content